已收盤 05-08 16:00:00 美东时间
+0.110
+0.70%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
华盛资讯5月6日讯,Sotera Health Company公布2026财年Q1业绩,公司Q1营收2.80亿美元,同比增长10.0%,归母净利润0.27亿美元,扭亏为盈。
05-06 06:01
On Tuesday, Sotera Health (NASDAQ:SHC) discussed first-quarter financial result...
05-05 21:58
Sotera Health (SHC) on Tuesday said it appointed Alton Shader as CEO, effective May 26, as part of a planned leadership transition. Shader, currently CEO of Viant Medical, will also join the company’s...
05-05 20:18
华盛资讯5月5日讯,Sotera Health Company公布2026财年Q1业绩,公司Q1营收2.80亿美元,同比增长10.0%,归母净利润0.27亿美元,扭亏为盈。
05-05 20:06
华盛资讯5月5日讯,Sotera Health Company公布2026财年Q1业绩,公司Q1营收2.80亿美元,同比增长10.0%,归母净利润0.27亿美元,扭亏为盈。
05-05 19:52
Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of DirectorsCLEVELAND,
05-05 19:25
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.17 by 0 percent. This is a 28.57 percent increase over earnings of $0.14 per share from the same
05-05 19:04
Sotera Health Company announced that Alton Shader, CEO of Viant Medical, will become its CEO and join the Board of Directors effective May 26, 2026. Michael B. Petras, Jr., the current Chairman and CEO, will serve as Executive Chairman to ensure a smooth leadership transition. Shader brings over 20 years of experience in the healthcare industry, having led Viant Medical through significant growth and expansion. Petras, who has served as CEO since...
05-05 11:00